Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 428-480-0 | CAS number: 214559-61-2 COLORANT Y-1189; DUASYN; DYE Y-1189; FARBSTOFF Y-1189; Y-1189; Y-1189L
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 5 May 1998 to 12 June 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, performed in accordance with valid guidelines and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Tetrasodium 7-[[4-[[4,6-bis[(3-sulfonatopropyl)thio]-1,3,5-triazin-2-yl]amino]-3-methoxyphenyl]azo]naphthalene-1,3-disulfonate
- EC Number:
- 428-480-0
- EC Name:
- Tetrasodium 7-[[4-[[4,6-bis[(3-sulfonatopropyl)thio]-1,3,5-triazin-2-yl]amino]-3-methoxyphenyl]azo]naphthalene-1,3-disulfonate
- Cas Number:
- 214559-61-2
- Molecular formula:
- C26H24N6O13S6Na4
- IUPAC Name:
- tetrasodium 7-[[4-[[4,6-bis[(3-sulfonatopropyl)thio]-1,3,5-triazin-2-yl]amino]-3-methoxyphenyl]azo]naphthalene-1,3-disulfonate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): Y-1189
- Physical state: solid
- Appearance: orange granulous powder
- Storage condition of test material: at room temperature and protected from light
Constituent 1
Method
- Target gene:
- S. typhimurium: Histidine locus
E. coli: Tryptophan locus
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- 0, 10, 100, 500, 1000, 2500, 5000 μg/plate (prelminary toxicity test with TA 98, TA 100 and WP2 uvrA, with and without S9 mix)
0, 312.5, 625, 1250, 2500, 5000 μg/plate (mutagenicity test 1 and 2, with and without S9 mix) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: distilled water
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- N-ethyl-N-nitro-N-nitrosoguanidine
- other: 2-anthramine
- Details on test system and experimental conditions:
- - Experiment 1 and Experiment 2 without S9 mix
METHOD OF APPLICATION: in agar (plate incorporation)
The day before treatment, cultures were inoculated from frozen permanents. A scrape was taken under sterile conditions and put into approximately 6 mL of nutrient broth. The nutrient broth was then placed under agitation in an incubator at 37 °C for about 14 hours.
0.05 to 0.1 mL of the test material solution, 0.5 mL of S9 mix (with S9 mix) and 0.1 mL of the strain were mixed with 2 mL of overlay agar (containing traces of the relevant amino acid and biotin and maintained at 45 °C). After rapid homogenisation, the mixture was overlaid onto a Petri plate containing minimum medium.
- Experiment 2 with S9 mix
METHOD OF APPLICATION: preincubation
The day before treatment, cultures were inoculated from frozen permanents. A scrape was taken under sterile conditions and put into approximately 6 mL of nutrient broth. The nutrient broth was then placed under agitation in an incubator at 37 °C for about 14 hours.
0.05 to 0.1 mL of the test material solution, 0.5 mL of S9 mix (with S9 mix) and 0.1 mL of the strain were incubated for 60 minutes at 37 °C prior to the addition of overlay agar. The mixture was then poured onto the surface of a minimum agar plate.
DURATION
- Exposure duration: Plates were incubated inverted at 37 °C for 48 to 72 hours in the dark.
NUMBER OF REPLICATIONS: Test concentrations were performed in triplicate (mutagenicity experiments) (one dose/plate in preliminary toxicity test)
EVALUATION PROCEDURE: Following the total incubation period, revertants were scored with an automatic counter.
DETERMINATION OF CYTOTOXICITY
- Method: Cytotoxicity was assessed as a reduction in the number of revertant colonies and/or a clearing of the background lawn of bacterial growth. - Evaluation criteria:
- The study was considered valid if the following were met:
- The number of revertants of the controls was within the range of historical control data
- The number of revertants of the positive controls was higher than that of the controls and within the range of historical data
Evaluation criteria:
A reproducible two-fold increase in the number of revertants compared with the vehicle controls, in any strain at any dose level and/or evidence of a dose-response relationship was considered as a positive result.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- - Preliminary Toxicity Test
The test material was found to be freely soluble in the vehicle (distilled water) at 50 mg/mL. Consequently, with a maximum dose volume of 100 µL/plate, the dose levels were 10, 100, 500, 1000, 2500 and 5000 µg/plate.
No precipitate was observed in the Petri plates when scoring the revertants at all dose levels. A slight orange-yellow colouration was noted in the plates at dose levels at and above 500 µg/plate. No toxicity was noted towards the three strains used, with and without S9 mix.
- Mutagenicity Experiments
The numbers of revertants of the vehicle and positive controls was as specified in the acceptance criteria; the study was therefore considered valid.
Since the test material was freely soluble and non-toxic, the highest dose-level was 5000 µg/plate.
No precipitate was observed in the Petri plates when scoring the revertants at all dose levels. A moderate orange-yellow colouration was noted in the plates at 5000 µg/plate. A slight colourations was observed at the remaining dose levels
- Experiments without S9 mix:
In the first experiment, a slight to moderate decrease in revertants was observed in both TA 1537 and TA 98 strains at dose levels at and above 2500 µg/plate. In the TA 1535 strain, a slight decrease in the number of revertants was noted in the plates at 5000 µg/plate. In the second experiment, except for slight decreases in the number of revertants noted in the TA 100 strain at dose levels at and above 1250 µg/plate, no notable toxicity was observed.
Overall, no noteworthy increase in the number of revertants was induced in all tester strains, in both experiments.
- Experiments with S9:
Except for a slight decrease in the number of revertants noted in the first experiment with the TA 98 strain at 5000 µg/plate, no notable toxicity was observed.
The test material did not induce any relevant increase in the number of revertants, in all tester strains in both experiments. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1: Experiment 1 Results
Strain |
Dose |
Without S9 |
With S9 |
||
Mean revertants/ plate |
Ratio |
Mean revertants/ plate |
Ratio |
||
TA 1535 |
0 |
14 |
- |
11 |
- |
30 |
10 |
0.76 |
15 |
1.44 |
|
100 |
12 |
0.88 |
12 |
1.09 |
|
300 |
11 |
0.80 |
12 |
1.13 |
|
1000 |
11 |
0.83 |
10 |
0.94 |
|
3000* |
8 |
0.61 |
9 |
0.88 |
|
NaN3 / 2AM |
323 |
23.63 |
214 |
20.03 |
|
TA 1537 |
0 |
7 |
- |
11 |
- |
30 |
6 |
0.90 |
12 |
1.13 |
|
100 |
8 |
1.14 |
11 |
1.00 |
|
300 |
6 |
0.90 |
12 |
1.13 |
|
1000 |
4 |
0.62 |
15 |
1.44 |
|
3000* |
3 |
0.38 |
13 |
1.25 |
|
9AA / 2AM |
334 |
47.71 |
268 |
25.16 |
|
TA 98 |
0 |
27 |
- |
27 |
- |
30 |
18 |
0.67 |
21 |
0.77 |
|
100 |
21 |
0.77 |
27 |
0.98 |
|
300 |
30 |
1.10 |
20 |
0.73 |
|
1000 |
17 |
0.61 |
22 |
0.79 |
|
3000* |
12 |
0.45 |
17 |
0.61 |
|
2NF / 2AM |
178 |
6.52 |
2340 |
85.61 |
|
TA 100 |
0 |
93 |
- |
110 |
- |
30 |
110 |
1.18 |
106 |
0.96 |
|
100 |
110 |
1.18 |
120 |
1.09 |
|
300 |
90 |
0.96 |
106 |
0.96 |
|
1000 |
95 |
1.02 |
99 |
0.90 |
|
3000* |
69 |
0.74 |
108 |
0.98 |
|
NaN3 / 2AM |
529 |
5.66 |
2902 |
26.30 |
|
E. coli WP2 uvr A |
0 |
46 |
- |
33 |
- |
30 |
48 |
1.04 |
28 |
0.84 |
|
100 |
45 |
0.98 |
29 |
0.88 |
|
300 |
44 |
0.96 |
32 |
0.96 |
|
1000 |
43 |
0.93 |
25 |
0.77 |
|
3000* |
39 |
0.84 |
28 |
0.84 |
|
4NQO / 2AM |
1738 |
37.78 |
323 |
9.80 |
Table 2: Experiment 2 Results
Strain |
Dose |
Without S9 |
With S9 |
||
Mean revertants/ plate |
Ratio |
Mean revertants/ plate |
Ratio |
||
TA 1535 |
0 |
8 |
- |
11 |
- |
30 |
15 |
1.80 |
12 |
1.16 |
|
100 |
11 |
1.32 |
11 |
1.06 |
|
300 |
9 |
1.12 |
13 |
1.22 |
|
1000 |
12 |
1.44 |
12 |
1.13 |
|
3000* |
8 |
1.00 |
15 |
1.41 |
|
NaN3 / 2AM |
404 |
48.48 |
314 |
29.44 |
|
TA 1537 |
0 |
7 |
- |
14 |
- |
30 |
6 |
0.81 |
11 |
0.79 |
|
100 |
12 |
1.67 |
11 |
0.81 |
|
300 |
7 |
1.05 |
15 |
1.05 |
|
1000 |
10 |
1.38 |
9 |
0.64 |
|
3000* |
9 |
1.33 |
12 |
0.83 |
|
9AA / 2AM |
289 |
41.24 |
195 |
13.93 |
|
TA 98 |
0 |
14 |
- |
20 |
- |
30 |
15 |
1.12 |
24 |
1.20 |
|
100 |
18 |
1.32 |
23 |
1.19 |
|
300 |
17 |
1.24 |
24 |
1.20 |
|
1000 |
15 |
1.12 |
22 |
1.14 |
|
3000* |
16 |
1.15 |
21 |
1.07 |
|
2NF / 2AM |
146 |
10.66 |
1664 |
84.63 |
|
TA 100 |
0 |
97 |
- |
106 |
- |
30 |
94 |
0.97 |
143 |
1.35 |
|
100 |
80 |
0.82 |
134 |
1.26 |
|
300 |
64 |
0.66 |
132 |
1.24 |
|
1000 |
58 |
0.60 |
120 |
1.14 |
|
3000* |
55 |
0.57 |
109 |
1.03 |
|
NaN3 / 2AM |
546 |
5.63 |
2459 |
23.20 |
|
E. coli WP2 uvr A |
0 |
33 |
- |
53 |
- |
30 |
31 |
0.93 |
44 |
0.83 |
|
100 |
26 |
0.79 |
47 |
0.88 |
|
300 |
26 |
0.78 |
39 |
0.73 |
|
1000 |
25 |
0.76 |
41 |
0.76 |
|
3000* |
29 |
0.88 |
40 |
0.74 |
|
4NQO / 2AM |
1369 |
41.49 |
214 |
4.01 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with and without metabolic activation
Under the specific conditions of this assay, the test material gave a negative (i.e. non-mutagenic), response in Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and E. coli strain WP2 uvrA both in the presence and absence of metabolic activation. The study is considered to be reliable, relevant and adequate for risk assessment and classification and labelling purposes. - Executive summary:
The potential of the test material to cause gene mutation in bacterial strains was determined in accordance with standardised guidelines OECD 471 and EU Method B.13/14. Four trains of Salmonella typhimurium (TA1535, TA1537, TA98 and TA100) and one strain of Escherichia coli (WP2 uvrA) were treated in the presence and absence of a metabolic activation system (S9 mix). In two separate assays, the test material did not induce any significant, reproducible increases in the observed number of revertant colonies in any of the tester strains used in the absence or absence of metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
